Lorbrena

Pfizer

Lorbrena is a prescription medicine for people living with anaplastic lymphoma kinase (ALK)+ non-small cell lung cancer that has spread to other parts of the body and is no longer responding to alectinib or ceritinib or crizotinib and at least one other ALK inhibitor medicine.

Lorbrena works by inhibiting the ALK protein to help slow the growth or spread of ALK+ tumors that have spread to other parts of the body.

The most common side effects include swelling in arms, legs, hands and feet, numbness and tingling feeling in joints or arms and legs, difficulty thinking or confusion, difficulty breathing, tiredness, Weight gain, joint pain, changes in mood, feeling sad or anxious and diarrhea.

Next >>